1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
DoD Peer Reviewed Cancer, Idea Award is sponsored by Department of Defense (DoD) -- USAMRAA. The Idea Award supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or basic cancer research that are relevant to active-duty Service Members, Veterans, other military beneficiaries, and the American public.
The intention is innovative basic research that may introduce a new paradigm, challenge existing paradigms, or look at existing problems from new perspectives. Inclusion of preliminary data is discouraged.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: The program description emphasizes innovative basic research and concepts relevant to military beneficiaries and the American public. Confirm the full requirements in the official notice before applying.
DoD Peer Reviewed Cancer, Idea Award is funded by Department of Defense (DoD) -- USAMRAA. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
DoD Rare Cancers, Idea Development Award is sponsored by Department of Defense (DoD) -- USAMRAA. This award promotes new ideas in the early stages of development with the potential to yield impactful data and new avenues of investigation for rare cancers, including sarcomas. It supports research based on preliminary data that could lead to critical discoveries or major advancements in eradicating deaths and suffering from rare cancers.
DoD Joint Warfighter Medical, Military Medical Research and Development Award is sponsored by Department of Defense (DoD) -- USAMRAA. This mechanism funds the logical continuation of previously DoD-funded research or development efforts with high potential to augment and accelerate medical product development and healthcare solutions for active-duty Service Members, their Families, Veterans, and/or the American public. A Clinical Research or Clinical Trial Option is available to support clinical research/observational studies, all phases of clinical trials/interventional studies, and/or correlative studies in support of medical devices and technologies.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read article